Long-acting central stimulant that induces self-injurious behavior in rats. Acts as an indirect monoamine agonist.
|Storage||Store at RT|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
|Solvent||Max Conc. mg/mL||Max Conc. mM|
|ethanol||1.76||10mM with gentle warming|
Preparing Stock Solutions
The following data is based on the product molecular weight 176.17. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||5.68 mL||28.38 mL||56.76 mL|
|5 mM||1.14 mL||5.68 mL||11.35 mL|
|10 mM||0.57 mL||2.84 mL||5.68 mL|
|50 mM||0.11 mL||0.57 mL||1.14 mL|
References are publications that support the products' biological activity.
Mueller and Nyhan (1982) Pharmacologic control of pemoline induced self-injurious behavior in rats. Pharmacol.Biochem.Behav. 16 957 PMID: 6213967
Kies and Devine (2004) Self-injurious behaviour: a comparison of caffeine and pemoline models in rats. Pharmacol.Biochem.Behav. 79 587 PMID: 15582667
Muehlmann et al (2008) Pemoline (2-Amino-5-phenyl-1,3-oxazol-4-one)-induced self-injurious behavior: a rodent model of pharmacotherapeutic efficacy. J.Pharmacol.Exp.Ther. 324 214 PMID: 17925479
If you know of a relevant reference for Pemoline, please let us know.
View Related Products by Target
Keywords: Pemoline, supplier, CNS, stimulant, indirect, monoamine, agonists, Dopaminergic, Dopamine, Receptors, Adrenergic, Compounds, Adrenoceptors, Serotonin, 5-HT-, 5-Hydroxytryptamine, Phenoxazole, Phenylisohydantoin, Dopaminergic-Related, Adrenergic, Related, Compounds, 5-HT-Related, 5-HT3, Receptors, Dopaminergic-Related, Tocris Bioscience
Citations for Pemoline
Citations are publications that use Tocris products.
Currently there are no citations for Pemoline. Do you know of a great paper that uses Pemoline from Tocris? If so please let us know.
Average Rating:(Based on 0 Reviews)
Literature in this Area
Dopamine Receptors Scientific Review
Written by Phillip Strange and revised by Kim Neve in 2013, this review summarizes the history of the dopamine receptors and provides an overview of individual receptor subtype properties, their distribution and identifies ligands which act at each receptor subtype. Compounds available from Tocris are listed.
Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.